Stéphane De Wit

1.4k total citations
38 papers, 704 citations indexed

About

Stéphane De Wit is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Stéphane De Wit has authored 38 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 16 papers in Epidemiology and 14 papers in Virology. Recurrent topics in Stéphane De Wit's work include HIV Research and Treatment (14 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (14 papers). Stéphane De Wit is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (14 papers). Stéphane De Wit collaborates with scholars based in Belgium, United Kingdom and United States. Stéphane De Wit's co-authors include Éric Florence, Brian Wynne, Jean van Wyk, Faïza Ajana, Nathan Clumeck, Mounir Ait‐Khaled, Keith A. Pappa, Ruolan Wang, Fiona Bisshop and Michael Aboud and has published in prestigious journals such as Clinical Infectious Diseases, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Stéphane De Wit

35 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane De Wit Belgium 13 508 328 175 153 79 38 704
Annette Haberl Germany 18 499 1.0× 285 0.9× 310 1.8× 154 1.0× 125 1.6× 56 868
Ryan Cooper Canada 12 562 1.1× 131 0.4× 277 1.6× 220 1.4× 133 1.7× 23 740
Duncan Churchill United Kingdom 17 720 1.4× 543 1.7× 241 1.4× 284 1.9× 68 0.9× 50 1.1k
JM Gatell Spain 13 593 1.2× 354 1.1× 282 1.6× 255 1.7× 39 0.5× 28 805
Emily Hopkins United States 18 443 0.9× 184 0.6× 432 2.5× 132 0.9× 77 1.0× 50 800
Paola Cicconi Italy 17 489 1.0× 369 1.1× 351 2.0× 301 2.0× 19 0.2× 45 881
Edmund Wilkins United Kingdom 13 604 1.2× 443 1.4× 154 0.9× 305 2.0× 21 0.3× 24 777
Leo Flamholc Sweden 17 487 1.0× 370 1.1× 413 2.4× 99 0.6× 46 0.6× 39 875
Teresa Bini Italy 17 622 1.2× 442 1.3× 278 1.6× 313 2.0× 33 0.4× 65 962
Manuel Crespo Spain 16 647 1.3× 423 1.3× 296 1.7× 266 1.7× 74 0.9× 40 927

Countries citing papers authored by Stéphane De Wit

Since Specialization
Citations

This map shows the geographic impact of Stéphane De Wit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane De Wit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane De Wit more than expected).

Fields of papers citing papers by Stéphane De Wit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane De Wit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane De Wit. The network helps show where Stéphane De Wit may publish in the future.

Co-authorship network of co-authors of Stéphane De Wit

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane De Wit. A scholar is included among the top collaborators of Stéphane De Wit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane De Wit. Stéphane De Wit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levin, Myron J., Andrew Ustianowski, Stéphane De Wit, et al.. (2024). Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials. Infectious Diseases and Therapy. 13(6). 1253–1268.
2.
Florence, Éric, Jean Cyr Yombi, Sophie Henrard, et al.. (2023). Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real‐world setting in Belgium. HIV Medicine. 24(8). 914–924. 14 indexed citations
3.
Vermeersch, Sebastian, Rémy Demeester, Steven Callens, et al.. (2022). A public health value-based healthcare paradigm for HIV. BMC Health Services Research. 22(1). 13–13. 6 indexed citations
4.
5.
Yombi, Jean Cyr, Gilles Darcis, Éric Florence, et al.. (2022). Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium. HIV Medicine. 24(3). 267–278. 8 indexed citations
6.
7.
Florence, Éric, Michel Moutschen, Jean Cyr Yombi, et al.. (2021). Clinical characteristics and outcomes of COVID‐19 in people living with HIV in Belgium: A multicenter, retrospective cohort. Journal of Medical Virology. 93(5). 2971–2978. 8 indexed citations
8.
Beckhoven, Dominique Van, Éric Florence, Stéphane De Wit, et al.. (2020). Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort. HIV Medicine. 21(9). 557–566. 11 indexed citations
9.
Martin, Charlotte, Isabel Montesinos, Nicolás Dauby, et al.. (2020). Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff. Journal of Hospital Infection. 106(1). 102–106. 64 indexed citations
10.
Hainaut, Marc, Patricia Barlow, Sigi Van den Wijngaert, et al.. (2019). High rate of rubella seronegativity in perinatally-infected HIV women of childbearing age: A case-control study. Vaccine. 37(40). 5930–5933. 2 indexed citations
11.
Wit, Stéphane De, Éric Florence, Linos Vandekerckhove, et al.. (2018). Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients. Acta Clinica Belgica. 73(5). 341–347.
12.
Vermeersch, Sebastian, Steven Callens, Stéphane De Wit, et al.. (2017). Health and budget impact of combined HIV prevention – first results of the BELHIVPREV model. Acta Clinica Belgica. 73(1). 54–67. 6 indexed citations
13.
Vooren, J P Van, et al.. (2017). Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB Strategy. Epidemiology and Infection. 145(7). 1368–1373. 1 indexed citations
14.
Sasse, André Deeke, Éric Florence, Anastasia Pharris, et al.. (2015). Late presentation to HIV testing is overestimated when based on the consensus definition. HIV Medicine. 17(3). 231–234. 19 indexed citations
15.
Berghe, Wim Vanden, Stéphane De Wit, Kabamba Kabeya, et al.. (2015). Risk Factors for HCV Acquisition Among HIV-Positive MSM in Belgium. JAIDS Journal of Acquired Immune Deficiency Syndromes. 68(5). 585–593. 49 indexed citations
16.
Beckhoven, Dominique Van, Patrick Lacor, Michel Moutschen, et al.. (2014). Factors associated with the continuum of care of HIV‐infected patients in Belgium. Journal of the International AIDS Society. 17(4S3). 19534–19534. 15 indexed citations
17.
Wit, Stéphane De, Pamela Donohue, Jennifer Shepard, & Renee D. Boss. (2012). Mother–clinician discussions in the neonatal intensive care unit: agree to disagree?. Journal of Perinatology. 33(4). 278–281. 20 indexed citations
18.
Vandekerckhove, Linos, Chris Verhofstede, Els Demecheleer, et al.. (2010). Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment. Journal of Antimicrobial Chemotherapy. 66(2). 265–272. 21 indexed citations
19.
Vandenbroucke, Ina, Herwig Van Marck, Wendy Mostmans, et al.. (2010). HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays. AIDS Research and Therapy. 7(1). 4–4. 32 indexed citations
20.
Hermans, Philippe, Michèle Gérard, Yves Van Laethem, Stéphane De Wit, & Nathan Clumeck. (1991). Pancreatic disturbances and typhoid fever. Scandinavian Journal of Infectious Diseases. 23(2). 201–205. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette Haberl Breakdown of academic impact, for papers by Ryan Cooper Breakdown of academic impact, for papers by Duncan Churchill Breakdown of academic impact, for papers by JM Gatell Breakdown of academic impact, for papers by Emily Hopkins Breakdown of academic impact, for papers by Paola Cicconi Breakdown of academic impact, for papers by Edmund Wilkins Breakdown of academic impact, for papers by Leo Flamholc Breakdown of academic impact, for papers by Teresa Bini Breakdown of academic impact, for papers by Manuel Crespo
Rankless by CCL
2026